Medtronic MiniMed Insulin Pump Problems Result in Recalls, Injuries and Deaths

By Harvey Kirk
Posted March 2, 2020

ADD YOUR COMMENTS

Last month, the FDA recalled more than 300,000 Medtronic MiniMed 600-series insulin pumps, following reports of thousands of injuries and at least one death due to problems with insulin overdoses and under-dosing.

The lawyers at Saiontz & Kirk, P.A. are reviewing Medtronic MiniMed Insulin Pump Recall Lawsuits to help determine whether financial compensation may be available for injuries that resulted from hyperglycemia (high levels of glucose) or hypoglycemia (low levels of glucose).

Contact Our Lawyers To Review Medtronic MiniMed Problems

• FIRST NAME:*
• LAST NAME:*
• PRIMARY PHONE:
• ALT. PHONE:
• EMAIL:
• DETAILS ABOUT CASE:
• Phone
  This field is for validation purposes and should be left unchanged.

Δ

*By submitting, you authorize Saiontz & Kirk, P.A. to send text messages to the numbers provided, including information & offers, possibly using automated technology. Message/data rates apply. Consent is not a condition for acceptance of services.

Symptoms of hyperglycemia include:

• Thirst
• Headaches
• Blurred Vision
• Problems Concentrating
• Fatigue
• Weight Loss
• Diabetic Ketoacidosis
• Death

Hypoglycemia symptoms include:

• Irregular Heartbeat
• Fatigue
• Anxiety
• Shakiness
• Hunger
• Vision Problems
• Confusion
• Seizures
• Loss of Consciousness
• Coma
• Death

The Medtronic MiniMed recall was announced on February 12, due to a risk that devices distributed since September 2016 may contain a broken or missing retainer ring, which may result in the delivery of too much or too little insulin.

More than 26,421 problems have been linked to the Medtronic MiniMed 600 series, which are small, computerized drug pumps which deliver insulin into the bodies of diabetic patients through a catheter implanted under the skin.

While the devices are supposed to wirelessly read data from glucose monitors to determine the appropriate dose of insulin to deliver, design and manufacturing defects may result in users receiving too much or too little insulin, with potentially catastrophic consequences for diabetics.

The FDA has already identified at least 2,175 reported injuries and one death, which likely only represents a small number of the actual problems linked to the recalled insulin pumps.

The recall affects 322,000 Medtronic MiniMed insulin pumps with model number 630G (MMT-1715), distributed from September 2016 through October 2019; and model number 670G (MMT-1780), distributed from June 2017 through August 2018.

The FDA warns that a ring which locks the insulin cartridge in place could be missing or broken in the affected pumps. This can result in the cartridge not being firmly locked in place, resulting in incorrect dosing.

Medtronic MiniMed Insulin Pump Lawyers

The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential lawsuits for individuals nationwide who have suffered injuries due to incorrect insulin delivery from Medtronic MiniMed Pumps.

Financial compensation may be available to those who have suffered from under-dosing or overdosing, resulting in serious injuries or the loss of a loved one.

All claims are handled on a contingency fee basis, meaning there are never any out-of-pocket expenses and no fees unless a recovery is obtained.

REQUEST A MEDTRONIC MINIMED RECALL CASE EVALUATION